Cyclosporin A-Derivative 1 is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1. Cyclosporin A is an immunosuppressive agent which can bind to the cyclophilin and inhibit calcineurin.
Cyclosporin A-Derivative 1 is a chemically modified analog of the well-known cyclic peptide cyclosporin A, engineered to retain the core structural motifs that confer its unique bioactivity while introducing specific alterations for enhanced research versatility. As a synthetic peptide derivative, it features a macrocyclic backbone with tailored side-chain modifications, enabling detailed investigation into structure-activity relationships within the cyclosporin family. Its distinctive molecular architecture makes it highly relevant for studies focused on peptide-protein interactions, conformational analysis, and the modulation of cellular signaling pathways. Researchers value this compound for its ability to serve as a tool in dissecting the biochemical mechanisms underlying peptide-mediated processes, as well as for its potential to inform the design of novel peptide-based agents in basic and applied science settings.
Peptide-Protein Interaction Studies: Cyclosporin A derivatives are widely utilized in research that seeks to elucidate the mechanisms of peptide-protein recognition and binding. The specific modifications present in Cyclosporin A-Derivative 1 allow for comparative analyses with the parent molecule, facilitating the identification of key residues responsible for interaction with target proteins such as cyclophilins and related immunophilins. By employing this derivative in binding assays and structural biology experiments, investigators can map interaction interfaces and gain insights into the dynamic conformational features that govern selectivity and affinity in peptide-protein complexes.
Structure-Activity Relationship (SAR) Analysis: The introduction of defined chemical modifications into the cyclosporin scaffold provides a strategic platform for SAR studies. Cyclosporin A-Derivative 1 serves as a model compound for systematic evaluation of how specific side-chain or backbone alterations influence biological activity, stability, and molecular recognition. Researchers leverage this derivative in comparative biochemical assays to dissect the contributions of individual functional groups, thereby supporting the rational design of next-generation cyclic peptides with tailored properties for research or industrial applications.
Peptide Synthesis and Method Development: As a representative of complex cyclic peptides, Cyclosporin A-Derivative 1 is frequently employed in the development and optimization of synthetic methodologies. Its intricate macrocyclic structure and diverse functional groups challenge conventional peptide synthesis techniques, making it an ideal substrate for testing novel coupling strategies, protecting group schemes, and cyclization protocols. The compound is also valuable in analytical method validation, where it serves as a benchmark for evaluating the efficiency and selectivity of chromatographic or spectrometric techniques applied to peptide analysis.
Cellular Signaling Pathway Research: The ability of cyclosporin analogs to modulate intracellular signaling cascades has made derivatives like this one important tools in cell biology. Cyclosporin A-Derivative 1 can be used to probe the involvement of peptidyl-prolyl isomerases and related proteins in signal transduction, protein folding, and trafficking events. By introducing this derivative into cultured cell systems, researchers can investigate alterations in downstream effectors, dissect pathway-specific responses, and explore the molecular consequences of peptide-mediated enzyme inhibition or modulation.
Conformational and Biophysical Studies: The macrocyclic nature of Cyclosporin A-Derivative 1 renders it highly suitable for advanced conformational analyses using techniques such as NMR spectroscopy, X-ray crystallography, and circular dichroism. Scientists utilize the derivative to study the interplay between peptide sequence, three-dimensional structure, and physicochemical properties. Such investigations are critical for understanding the principles that govern peptide folding, stability, and membrane permeability, ultimately informing the design of novel cyclic peptides for diverse research applications.
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More